Kim Biermann

451 total citations
13 papers, 331 citations indexed

About

Kim Biermann is a scholar working on Radiology, Nuclear Medicine and Imaging, Endocrinology, Diabetes and Metabolism and Epidemiology. According to data from OpenAlex, Kim Biermann has authored 13 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Radiology, Nuclear Medicine and Imaging, 5 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Epidemiology. Recurrent topics in Kim Biermann's work include Neuroendocrine Tumor Research Advances (3 papers), Thyroid Cancer Diagnosis and Treatment (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). Kim Biermann is often cited by papers focused on Neuroendocrine Tumor Research Advances (3 papers), Thyroid Cancer Diagnosis and Treatment (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). Kim Biermann collaborates with scholars based in Germany, Australia and Switzerland. Kim Biermann's co-authors include Hans‐Jürgen Biersack, Amir Sabet, Samer Ezziddin, Holger Brockmann, Hojjat Ahmadzadehfar, Kai Wilhelm, Christiane Kühl, Alexius Joe, Stefan Guhlke and Eva Wardelmann and has published in prestigious journals such as Thrombosis and Haemostasis, Journal of Nuclear Medicine and Journal of Psychiatric Research.

In The Last Decade

Kim Biermann

13 papers receiving 318 citations

Peers

Kim Biermann
Kim Biermann
Citations per year, relative to Kim Biermann Kim Biermann (= 1×) peers Kangqiang Peng

Countries citing papers authored by Kim Biermann

Since Specialization
Citations

This map shows the geographic impact of Kim Biermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim Biermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim Biermann more than expected).

Fields of papers citing papers by Kim Biermann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kim Biermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim Biermann. The network helps show where Kim Biermann may publish in the future.

Co-authorship network of co-authors of Kim Biermann

This figure shows the co-authorship network connecting the top 25 collaborators of Kim Biermann. A scholar is included among the top collaborators of Kim Biermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim Biermann. Kim Biermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Sabet, Amir, Ina Binse, Semih Doğan, et al.. (2016). Distinguishing synchronous from metachronous manifestation of distant metastases: a prognostic feature in differentiated thyroid carcinoma. European Journal of Nuclear Medicine and Molecular Imaging. 44(2). 190–195. 14 indexed citations
2.
Ahmadzadehfar, Hojjat, Amir Sabet, Kai Wilhelm, et al.. (2011). The significance of bremsstrahlung SPECT/CT after yttrium-90 radioembolization treatment in the prediction of extrahepatic side effects. European Journal of Nuclear Medicine and Molecular Imaging. 39(2). 309–315. 39 indexed citations
3.
Biermann, Kim, Hans‐Jürgen Biersack, Amir Sabet, & Viktor Janzen. (2011). Alternative Therapeutic Approaches in the Treatment of Primary and Secondary Dedifferentiated and Medullary Thyroid Carcinoma. Seminars in Nuclear Medicine. 41(2). 139–148. 12 indexed citations
4.
Biersack, Hans‐Jürgen & Kim Biermann. (2011). The Marine-Lenhart syndrome revisited. Wiener klinische Wochenschrift. 123(15-16). 459–462. 13 indexed citations
6.
Brockmann, Holger, Astrid Zobel, Anna Schuhmacher, et al.. (2010). Influence of 5-HTTLPR polymorphism on resting state perfusion in patients with major depression. Journal of Psychiatric Research. 45(4). 442–451. 17 indexed citations
7.
Ahmadzadehfar, Hojjat, Amir Sabet, Kim Biermann, et al.. (2010). The Significance of 99mTc-MAA SPECT/CT Liver Perfusion Imaging in Treatment Planning for 90Y-Microsphere Selective Internal Radiation Treatment. Journal of Nuclear Medicine. 51(8). 1206–1212. 86 indexed citations
8.
Ezziddin, Samer, Kim Biermann, Amir Sabet, et al.. (2010). Impact of the Ki-67 proliferation index on response to peptide receptor radionuclide therapy. European Journal of Nuclear Medicine and Molecular Imaging. 38(3). 459–466. 82 indexed citations
10.
Brockmann, Holger, Astrid Zobel, Alexius Joe, et al.. (2009). The value of HMPAO SPECT in predicting treatment response to citalopram in patients with major depression. Psychiatry Research Neuroimaging. 173(2). 107–112. 42 indexed citations
11.
Joe, Alexius, Samer Ezziddin, Kim Biermann, et al.. (2008). Subclinical hyperthyroidism seems not to have a significant impact on systemic anticoagulation in patients with coumarin therapy. Thrombosis and Haemostasis. 100(5). 803–809. 3 indexed citations
12.
Ezziddin, Samer, Stefan Guhlke, H. Palmedo, et al.. (2007). Targeted radiotherapy of neuroendocrine tumors using Lu-177-DOTA octreotate with prolonged intervals. 48. 3 indexed citations
13.
Reinhardt, Michaël, Kim Biermann, Michael Wissmeyer, et al.. (2006). Dose selection for radioiodine therapy of borderline hyperthyroid patients according to thyroid uptake of 99mTc-pertechnetate: applicability to unifocal thyroid autonomy?. European Journal of Nuclear Medicine and Molecular Imaging. 33(5). 608–612. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026